A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis

NCT04368806 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: JointStem
OTHER: Placebo Control

Sponsor

Nature Cell Co. Ltd.